Number of employees
125
Annual revenue
$8000000
454 Life Sciences™ is commercializing novel instrumentation and services for rapidly and comprehensively conducting high-throughput nucleotide sequencing, with specific application to the sequencing of whole genomes and ultra-deep sequencing of target genes. The Company's successful submission of a complete adenovirus sequence to GenBank in 2003 marked the first time a new technology was used to sequence a whole genome since Walter Gilbert and Frederick Sanger won the Nobel Prize in 1980 for their invention of DNA sequencing in 1977.